Choline Magnesium Trisalicylate
Tricosal®; Trilisate® Management of osteoarthritis, rheumatoid arthritis, and other arthritis; salicylate salts may not inhibit platelet aggregation and, therefore, should not be substituted for aspirin in the prophylaxis of thrombosis; acute painful shoulder C/D (3rd trimester) Hypersensitivity to salicylates, other nonacetylated salicylates, other NSAIDs, or any component of the formulation; tartrazine dye hypersensitivity; bleeding disorders; pregnancy (3rd trimester) Use with caution in patients with impaired renal function, dehydration, erosive gastritis, asthma, or peptic ulcer; avoid use in patients with suspected varicella or influenza (salicylates have been associated with Reye's syndrome in children <16 years of age when used to treat symptoms of chickenpox or the flu). Discontinue use 1 week prior to surgical procedures.Elderly are a high-risk population for adverse effects from NSAIDs. As many as 60% of elderly can develop peptic ulceration and/or hemorrhage asymptomatically. Use lowest effective dose for shortest period possible. Tinnitus or impaired hearing may indicate toxicity. Tinnitus may be a difficult and unreliable indication of toxicity due to age-related hearing loss or eighth cranial nerve damage. CNS adverse effects may be observed in the elderly at lower doses than younger adults.
<20%:
Gastrointestinal: Nausea, vomiting, diarrhea, heartburn, dyspepsia, epigastric pain, constipation
Ocular: Tinnitus
<2%:
Central nervous system: Headache, lightheadedness, dizziness, drowsiness, lethargy
Ocular: Hearing impairment
<1%: Gastric ulceration, occult bleeding, increased BUN and creatinine, rash, pruritus, anorexia, weight gain, edema, epistaxis, dysgeusia
Decreased effect: Antacids + Trilisate®
decreased salicylate concentration; ACE-inhibitor effects may be decreased by concurrent therapy with NSAIDs
Increased toxicity: Warfarin + Trilisate®
possible increased hypoprothrombinemic effect
Children <37 kg: 50 mg/kg/day given in 2 divided doses
Adults: 500 mg to 1.5 g 2-3 times/day; usual maintenance dose: 1-4.5 g/day
Dosing adjustment/comments in renal impairment: Avoid use in severe renal impairment
Liquid: 500 mg/5 mL total salicylate (293 mg/5 mL choline salicylate and 362 mg/5 mL magnesium salicylate)
Tablet:
500 mg total salicylate (293 mg choline salicylate and 362 mg magnesium salicylate)
750 mg total salicylate (440 mg choline salicylate and 544 mg magnesium salicylate)
1000 mg total salicylate (587 mg choline salicylate and 725 mg magnesium salicylate)